These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1280 related articles for article (PubMed ID: 30276864)

  • 1. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical recurrence-free conditional probability after radical prostatectomy: A dynamic prognosis.
    García-Barreras S; Sanchez-Salas R; Mejia-Monasterio C; Muttin F; Secin F; Dell'Oglio P; Nunes-Silva I; Srougi V; Barret E; Rozet F; Prapotnich D; Cathelineau X
    Int J Urol; 2019 Jul; 26(7):725-730. PubMed ID: 31001870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Recovery, Oncologic Outcomes and Postoperative Complications after Robot-Assisted Radical Prostatectomy: An Evidence-Based Analysis Comparing the Retzius Sparing and Standard Approaches.
    Menon M; Dalela D; Jamil M; Diaz M; Tallman C; Abdollah F; Sood A; Lehtola L; Miller D; Jeong W
    J Urol; 2018 May; 199(5):1210-1217. PubMed ID: 29225060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
    Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
    J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pragmatic Randomized Controlled Trial Examining the Impact of the Retzius-sparing Approach on Early Urinary Continence Recovery After Robot-assisted Radical Prostatectomy.
    Dalela D; Jeong W; Prasad MA; Sood A; Abdollah F; Diaz M; Karabon P; Sammon J; Jamil M; Baize B; Simone A; Menon M
    Eur Urol; 2017 Nov; 72(5):677-685. PubMed ID: 28483330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retzius-sparing robot-assisted radical prostatectomy improves early recovery of urinary continence: a randomized, controlled, single-blind trial with a 1-year follow-up.
    Qiu X; Li Y; Chen M; Xu L; Guo S; Marra G; Elliot Rosenberg J; Ma H; Li X; Guo H
    BJU Int; 2020 Nov; 126(5):633-640. PubMed ID: 32741099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Bates AS; Mouraviev V; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Jun; 11(2):129-138. PubMed ID: 27435701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients.
    Hashimoto T; Yoshioka K; Nagao G; Nakagami Y; Ohno Y; Horiguchi Y; Namiki K; Nakashima J; Tachibana M
    Int J Urol; 2015 Feb; 22(2):188-93. PubMed ID: 25339062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up.
    Rajan P; Hagman A; Sooriakumaran P; Nyberg T; Wallerstedt A; Adding C; Akre O; Carlsson S; Hosseini A; Olsson M; Egevad L; Wiklund F; Steineck G; Wiklund NP
    Eur Urol Focus; 2018 Apr; 4(3):351-359. PubMed ID: 28753802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retzius Sparing Robot-Assisted Radical Prostatectomy Conveys Early Regain of Continence over Conventional Robot-Assisted Radical Prostatectomy: A Propensity Score Matched Analysis of 1,863 Patients.
    Lee J; Kim HY; Goh HJ; Heo JE; Almujalhem A; Alqahtani AA; Chung DY; Chang K; Choi YD; Rha KH
    J Urol; 2020 Jan; 203(1):137-144. PubMed ID: 31347951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients.
    Sukumar S; Rogers CG; Trinh QD; Sammon J; Sood A; Stricker H; Peabody JO; Menon M; Diaz-Insua M
    BJU Int; 2014 Dec; 114(6):824-31. PubMed ID: 24053586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy.
    Hashimoto T; Nakashima J; Inoue R; Komori O; Yamaguchi Y; Kashima T; Satake N; Nakagami Y; Namiki K; Nagao T; Ohno Y
    Int J Clin Oncol; 2020 Feb; 25(2):377-383. PubMed ID: 31673831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy.
    Song W; Jeon HG; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Int J Urol; 2016 Jan; 23(1):56-61. PubMed ID: 26502086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years.
    Sooriakumaran P; Haendler L; Nyberg T; Gronberg H; Nilsson A; Carlsson S; Hosseini A; Adding C; Jonsson M; Ploumidis A; Egevad L; Steineck G; Wiklund P
    Eur Urol; 2012 Nov; 62(5):768-74. PubMed ID: 22633365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
    Yashi M; Nukui A; Tokura Y; Takei K; Suzuki I; Sakamoto K; Yuki H; Kambara T; Betsunoh H; Abe H; Fukabori Y; Nakazato Y; Kaji Y; Kamai T
    BMC Urol; 2017 Jun; 17(1):47. PubMed ID: 28645325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer.
    Chenam A; Ruel N; Pal S; Barlog J; Lau C; Wilson T; Yuh B
    Can J Urol; 2018 Jun; 25(3):9340-9348. PubMed ID: 29900823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen screening impacts on biochemical recurrence in patients with clinically localized prostate cancer.
    Hashimoto T; Ohori M; Shimodaira K; Kaburaki N; Hirasawa Y; Satake N; Gondo T; Nakagami Y; Namiki K; Ohno Y
    Int J Urol; 2018 Jun; 25(6):561-567. PubMed ID: 29633374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.